Immobilized Her2 at 0.5 μg/ml (50μl /well) can bind to Trastuzumab with a linear range of 1.37 ng/ml to 10 μg/ml.
Product Details
Product Details
Product Specification
Host | Human |
Clone Number | S-SC007 |
Antibody Type | Recombinant mAb |
Isotype | IgG1 |
Application | Blocking of HER2 signaling Functional assays |
Purification | Protein G |
Concentration | 2 mg/ml |
Endotoxin | <1EU/mg |
Conjugation | Unconjugated |
Physical Appearance | Liquid |
Storage Buffer | PBS pH7.4, containing no preservative. |
Stability & Storage | 12 months from date of receipt / reconstitution, 2 to 8 °C as supplied |
Dilution
application | dilution | species |
ELISA | 1.37-10000 ng/ml |
Background
Trastuzumab, sold under the brand name Herceptin among others, is a monoclonal antibody used to treat breast cancer and stomach cancer. It is specifically used for cancer that is HER2 receptor positive. It may be used by itself or together with other chemotherapy medication. Trastuzumab is given by slow injection into a vein and injection just under the skin.
Picture
Picture
ELISA
